52992-82-2 Usage
Uses
Used in Pharmaceutical Industry:
Acetylisocupressic acid is used as an anti-inflammatory agent for its ability to inhibit the enzyme 15-lipoxygenase, which is involved in the inflammation process. This makes it a potential candidate for the development of drugs targeting inflammatory conditions.
Used in Antioxidant Applications:
Due to its antioxidant properties, acetylisocupressic acid is used to protect cells from oxidative damage, which can contribute to various health issues and the aging process.
Used in Antimicrobial Treatments:
Acetylisocupressic acid is used as an antimicrobial agent against a variety of bacteria and fungi, suggesting its potential for use in treating infections and contributing to the development of new antibiotics.
Further research on acetylisocupressic acid may reveal additional therapeutic applications and potential benefits for human health, expanding its use across various medical and healthcare industries.
Check Digit Verification of cas no
The CAS Registry Mumber 52992-82-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,9,9 and 2 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 52992-82:
(7*5)+(6*2)+(5*9)+(4*9)+(3*2)+(2*8)+(1*2)=152
152 % 10 = 2
So 52992-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C22H34O4/c1-15(12-14-26-17(3)23)8-10-19-16(2)9-11-20-18(21(24)25-5)7-6-13-22(19,20)4/h12,18-20H,2,6-11,13-14H2,1,3-5H3/b15-12+/t18-,19-,20+,22-/m0/s1
52992-82-2Relevant academic research and scientific papers
Iwamoto, Manabu,Minami, Toshifumi,Tokuda, Harukuni,Ohtsu, Hironori,Tanaka, Reiko
, p. 69 - 72 (2003)
Six diterpenes, including one new natural product, were isolated from a CHCl3 extract of the stem bark of Thuja standishii. The new compound has been characterized as 15-oxolabda-8(17),13Z-dien-19-oic acid. The known compounds were identified as ferruginol (2), sugiol (3), isocupressic acid (4), sandaracopimaric acid (5) and 15-oxolabda-8(17),13E-dien-19-oic acid (6). Compounds 2-5 and the derivatives 4a and 4b were tested for their inhibitory effects on Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA). Compounds 2, 3, 4 and 5 showed strong inhibitory effect on EBV-EA induction (100% inhibition at 1000 mol ratio/TPA).
